MSB 1.36% $1.12 mesoblast limited

Cell Therapy News/Articles, page-2227

  1. 1,249 Posts.
    lightbulb Created with Sketch. 1396
    No worries @howie1300 Very large numbers of people who have "recovered" from the pulmonary ravages of Covid-19 are in fact permanently crippled by that damage. In this context, the word "recovered" just means they didn't die. They are far from healthy and leading lives of any quality. They are already there and suffering, regardless of any future decline in death rates.

    There is also increasing appreciation of the physical harm far wider than ARDS. Heart, intestine, kidneys, all circulation, are all considered at risk. Benefit for these areas from Rem-L is not yet proven as far as I know, but there is good reason to think that it could help. And transform lives. And salvage health facilities and budgets.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.12
Change
0.015(1.36%)
Mkt cap ! $1.278B
Open High Low Value Volume
$1.13 $1.16 $1.10 $7.169M 6.411M

Buyers (Bids)

No. Vol. Price($)
4 7296 $1.12
 

Sellers (Offers)

Price($) Vol. No.
$1.12 43068 1
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.